Report

Global Recombinant Proteins Manufacturing Services Market Size study, by Service Type, by Host Cell, by End-user, and Regional Forecasts 2022-2032

  • Publish Date: Sep,2024
  • Report ID: 03-06-1943
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Global Recombinant Proteins Manufacturing Services Market Executive Summary
1.1. Global Recombinant Proteins Manufacturing Services Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Service Type
1.3.2. By Host Cell
1.3.3. By End-user
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Recombinant Proteins Manufacturing Services Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Recombinant Proteins Manufacturing Services Market Dynamics
3.1. Market Drivers
3.1.1. Expansion of the Biopharmaceutical Industry
3.1.2. Personalized Medicine and Targeted Therapies
3.1.3. Rising Prevalence of Chronic Diseases
3.2. Market Challenges
3.2.1. High Costs and Complex Manufacturing Processes
3.2.2. Regulatory and Quality Compliance
3.3. Market Opportunities
3.3.1. Advancements in Recombinant Technology
3.3.2. Growing Demand in Emerging Markets
3.3.3. Innovations in Gene Editing Technologies
Chapter 4. Global Recombinant Proteins Manufacturing Services Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Recombinant Proteins Manufacturing Services Market Size & Forecasts by Service Type 2022-2032
5.1. Segment Dashboard
5.2. Global Recombinant Proteins Manufacturing Services Market: Service Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Pre-clinical & Clinical Services
5.2.2. Commercial Production Services
Chapter 6. Global Recombinant Proteins Manufacturing Services Market Size & Forecasts by Host Cell 2022-2032
6.1. Segment Dashboard
6.2. Global Recombinant Proteins Manufacturing Services Market: Host Cell Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Mammalian Cells
6.2.2. Bacterial Cells
6.2.3. Insect Cells
6.2.4. Yeast & Fungi
6.2.5. Others
Chapter 7. Global Recombinant Proteins Manufacturing Services Market Size & Forecasts by End-user 2022-2032
7.1. Segment Dashboard
7.2. Global Recombinant Proteins Manufacturing Services Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Academic & Research Institutes
Chapter 8. Global Recombinant Proteins Manufacturing Services Market Size & Forecasts by Region 2022-2032
8.1. North America Recombinant Proteins Manufacturing Services Market
8.1.1. U.S. Recombinant Proteins Manufacturing Services Market
8.1.1.1. Service Type breakdown size & forecasts, 2022-2032
8.1.1.2. Host Cell breakdown size & forecasts, 2022-2032
8.1.1.3. End-user breakdown size & forecasts, 2022-2032
8.1.2. Canada Recombinant Proteins Manufacturing Services Market
8.2. Europe Recombinant Proteins Manufacturing Services Market
8.2.1. U.K. Recombinant Proteins Manufacturing Services Market
8.2.2. Germany Recombinant Proteins Manufacturing Services Market
8.2.3. France Recombinant Proteins Manufacturing Services Market
8.2.4. Spain Recombinant Proteins Manufacturing Services Market
8.2.5. Italy Recombinant Proteins Manufacturing Services Market
8.2.6. Rest of Europe Recombinant Proteins Manufacturing Services Market
8.3. Asia-Pacific Recombinant Proteins Manufacturing Services Market
8.3.1. China Recombinant Proteins Manufacturing Services Market
8.3.2. India Recombinant Proteins Manufacturing Services Market
8.3.3. Japan Recombinant Proteins Manufacturing Services Market
8.3.4. Australia Recombinant Proteins Manufacturing Services Market
8.3.5. South Korea Recombinant Proteins Manufacturing Services Market
8.3.6. Rest of Asia Pacific Recombinant Proteins Manufacturing Services Market
8.4. Latin America Recombinant Proteins Manufacturing Services Market
8.4.1. Brazil Recombinant Proteins Manufacturing Services Market
8.4.2. Mexico Recombinant Proteins Manufacturing Services Market
8.4.3. Rest of Latin America Recombinant Proteins Manufacturing Services Market
8.5. Middle East & Africa Recombinant Proteins Manufacturing Services Market
8.5.1. Saudi Arabia Recombinant Proteins Manufacturing Services Market
8.5.2. South Africa Recombinant Proteins Manufacturing Services Market
8.5.3. Rest of Middle East & Africa Recombinant Proteins Manufacturing Services Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Lonza
9.1.2. Boehringer Ingelheim International GmbH
9.1.3. FUJIFILM Diosynth Biotechnologies
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Lonza
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Boehringer Ingelheim International GmbH
9.3.3. FUJIFILM Diosynth Biotechnologies
9.3.4. Merck KGaA
9.3.5. Bruker (InVivo BioTech Services GmbH)
9.3.6. Sino Biological, Inc.
9.3.7. GenScript
9.3.8. Kaneka Corporation (Kaneka Eurogentec S.A)
9.3.9. Polyplus Transfection (Xpress Biologics)
9.3.10. Boster Biological Technology
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes